Repeated dosing of AAV-mediated liver gene therapy in juvenile rat and mouse models of Crigler-Najjar syndrome type I.

MLA

Shi, Xiaoxia, et al. “Repeated Dosing of AAV-Mediated Liver Gene Therapy in Juvenile Rat and Mouse Models of Crigler-Najjar Syndrome Type I.” Molecular Therapy. Methods & Clinical Development, vol. 32, no. 4, Oct. 2024, p. 101363. EBSCOhost, https://doi.org/10.1016/j.omtm.2024.101363.

APA

Shi, X., Bortolussi, G., Collaud, F., Lebrun, P.-R., Bloemendaal, L. T., Guerchet, N., Rudi de Waart, D., Sellier, P., Duijst, S., Veron, P., Mingozzi, F., Kishimoto, T. K., Ronzitti, G., Bosma, P., & Muro, A. F. (2024). Repeated dosing of AAV-mediated liver gene therapy in juvenile rat and mouse models of Crigler-Najjar syndrome type I. Molecular Therapy. Methods & Clinical Development, 32(4), 101363. https://doi.org/10.1016/j.omtm.2024.101363

Chicago

Shi, Xiaoxia, Giulia Bortolussi, Fanny Collaud, Pierre-Romain Lebrun, Lysbeth Ten Bloemendaal, Nicolas Guerchet, Dirk Rudi de Waart, et al. 2024. “Repeated Dosing of AAV-Mediated Liver Gene Therapy in Juvenile Rat and Mouse Models of Crigler-Najjar Syndrome Type I.” Molecular Therapy. Methods & Clinical Development 32 (4): 101363. doi:10.1016/j.omtm.2024.101363.